Mannatech vs Natural Alternatives International
MTEX and NAII side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MTEX and NAII compare
Natural Alternatives International is the larger company, worth 1.8 times as much as Mannatech ($21.4M against $12.2M).
Natural Alternatives International grew revenue faster over the last twelve months (−1.1% versus −6.6% for Mannatech).
Mannatech keeps more of each dollar of sales as profit, with a net margin of −0.41% compared with −17.2% at Natural Alternatives International.
Mannatech scores higher on the StockData Score (9 against 8 for Natural Alternatives International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MTEX | NAII |
|---|---|---|
| Size and price | ||
| Market cap | $12.2M | $21.4M |
| Share price | $6.30 | $0.967 |
| Change, 1 year | −33.8% | −65.6% |
| Change, 5 years | −83.5% | −92.9% |
| Beta (5Y) | 0.36 | 0.18 |
| Employees | 387 | 219 |
| StockData Score | ||
| Total score | 9 (better) | 8 |
| Valuation score | 3 (better) | 1 |
| Growth score | 0 | 0 |
| Performance score | 4 (better) | 2 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.1× (better) | 0.2× |
| P/B | 2.3× | 0.5× (better) |
| EV/EBITDA | 4.8× | – |
| FCF yield | −5.3% (better) | −31.0% |
| Fair value | $11.41 | – |
| Margin of safety | 44.8% | – |
| Growth | ||
| Revenue growth (TTM) | −6.6% | −1.1% (better) |
| Revenue growth, 5Y average | −6.5% | −4.4% (better) |
| Profitability | ||
| Gross margin | 75.7% (better) | 4.4% |
| Operating margin | 0.91% (better) | −16.3% |
| Net margin | −0.41% (better) | −17.2% |
| FCF margin | −0.63% (better) | −5.0% |
| Return on equity | −7.0% (better) | −39.4% |
| Return on invested capital | 17.8% (better) | −30.9% |
| Financial health | ||
| Debt / equity | 0.53 (better) | 0.00 |
| Net debt / EBITDA | −1.36 | – |
| Interest coverage | 2.0× | – |
| Current ratio | 1.18 | 1.37 (better) |
| Altman Z-score | 4.10 (better) | 1.32 |
| Piotroski F-score | 2 | 2 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.41% |
| Shareholder yield | 0.00% | 0.41% (better) |
| Ownership | ||
| Held by institutions | 7.9% | 10.5% |
| Held by insiders | – | 5.0% |
| Insider net buying, 12 months | $62.2K (better) | $26.8K |
| Short interest, % of float | – | 0.03% |
Go deeper
- MTEX stock overview
- MTEX income statement
- MTEX valuation and score
- NAII stock overview
- NAII income statement
- NAII valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.